[Antioxidative properties of cardioactive agents]

Area of Science:

• Cardiovascular Pharmacology
• Nephrotoxicology
• Oxidative Stress Biology

Context:

• Ischemia-reperfusion injury damages the myocardium, with free oxygen radicals implicated in its pathogenesis.
• The protective mechanisms of calcium entry blockers against this injury are not fully understood and may be independent of calcium channel blockade.
• Cisplatin, an antineoplastic drug, exhibits renal toxicity potentially mediated by pro-oxidative effects.

Purpose:

• To investigate the antioxidant properties of calcium entry blockers (nifedipine, verapamil, diltiazem) and their role in mitigating myocardial ischemia-reperfusion injury.
• To evaluate the efficacy of stobadine, an antioxidant with antiarrhythmic and antihypoxic properties, in counteracting the pro-oxidative effects and renal toxicity of cisplatin.

Summary:

• Calcium entry blockers nifedipine, verapamil, and diltiazem demonstrated significant free oxygen radical scavenging capabilities.
• This antioxidant characteristic is proposed as a key factor in their protective action against myocardial damage induced by ischemia and reperfusion.
• Stobadine effectively inhibited the pro-oxidative effects of cisplatin, suggesting its potential to mitigate cisplatin-induced renal toxicity.

Impact:

• Findings suggest that the antioxidant activity of calcium entry blockers contributes to their cardioprotective effects.
• The study highlights the potential of co-administering antioxidants like stobadine with cisplatin to prevent nephrotoxicity.
• This research opens avenues for developing novel therapeutic strategies targeting oxidative stress in cardiovascular and renal diseases.